切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2026, Vol. 20 ›› Issue (06) : 597 -601. doi: 10.3877/cma.j.issn.1674-3946.2026.06.019

综述

胃肠外科手术患者围手术期下肢深静脉血栓形成的风险评估与防治进展
邢维娜, 李冬蓉, 王素芳, 朱鸿飞†()   
  1. 102218 北京,清华大学北京清华长庚医院麻醉手术中心
  • 收稿日期:2026-05-28 出版日期:2026-12-26
  • 通信作者: 朱鸿飞

Risk assessment and prevention of deep vein thrombosis in the lower extremities during the perioperative period for patients undergoing gastrointestinal surgery

Weina Xing, Dongrong Li, Sufang Wang, Hongfei Zhu†()   

  1. Anesthesia and Surgery Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing 102218, China
  • Received:2026-05-28 Published:2026-12-26
  • Corresponding author: Hongfei Zhu
引用本文:

邢维娜, 李冬蓉, 王素芳, 朱鸿飞. 胃肠外科手术患者围手术期下肢深静脉血栓形成的风险评估与防治进展[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(06): 597-601.

Weina Xing, Dongrong Li, Sufang Wang, Hongfei Zhu. Risk assessment and prevention of deep vein thrombosis in the lower extremities during the perioperative period for patients undergoing gastrointestinal surgery[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2026, 20(06): 597-601.

下肢深静脉血栓形成(DVT)是胃肠外科手术患者围手术期常见且可预防的并发症,可进展为肺血栓栓塞症(PTE)并危及生命。胃肠外科患者疾病谱复杂,常合并恶性肿瘤、肠梗阻、腹腔感染、炎症性肠病、营养不良、术前肠道准备、围手术期禁食、术后活动受限及消化道或吻合口出血风险,导致血栓形成风险与出血风险长期并存。近年来,随着加速康复外科、腹腔镜及机器人手术、电子化风险评估系统、机器学习预测模型和新型抗凝药物的发展,胃肠外科围手术期静脉血栓栓塞症管理逐渐由经验性预防转向分层化、动态化和个体化管理。本文围绕胃肠外科围手术期DVT的流行病学特征、专科化发生机制、危险因素、风险评估工具、预防策略、诊断治疗衔接及质量管理进行综述,重点讨论Caprini评分“天花板效应”、直接口服抗凝药在胃肠道肿瘤术后应用安全性及延长预防适用人群等争议。本文认为,胃肠外科围手术期DVT管理不应依赖单一评分或固定抗凝路径,而应建立“基础评分-专科变量-出血风险-动态复评-出院随访”相结合的闭环管理模式,以期为临床规范化防治提供参考。

Deep vein thrombosis (DVT) of the lower extremities is a common yet preventable perioperative complication in patients undergoing gastrointestinal surgery, which may progress to life-threatening pulmonary embolism (PTE). Gastrointestinal surgical patients often present with complex disease profiles, frequently complicated by malignancy, intestinal obstruction, intra-abdominal infection, inflammatory bowel disease, malnutrition, preoperative bowel preparation, perioperative fasting, postoperative mobility limitations, and risks of gastrointestinal or anastomotic bleeding. These factors result in a prolonged coexistence of both thrombotic and bleeding risks. In recent years, advances in enhanced recovery after surgery, laparoscopic and robotic techniques, electronic risk assessment systems, machine learning prediction models, and novel anticoagulants have gradually shifted management of venous thromboembolism (VTE) in gastrointestinal surgery from empirical prevention toward stratified, dynamic, and individualized approaches. This review focuses on the epidemiological characteristics, specialized pathogenesis, risk factors, risk assessment tools, preventive strategies, diagnostic-treatment integration, and quality management of perioperative DVT in gastrointestinal surgery, with particular emphasis on controversies such as the "ceiling effect" of the Caprini score, the safety of direct oral anticoagulants following gastrointestinal cancer surgery, and the appropriate patient populations for extended prophylaxis. The authors argue that perioperative DVT management in gastrointestinal surgery should not rely solely on single scoring systems or fixed anticoagulation protocols, but instead adopt a closed-loop model integrating baseline scoring, specialty-specific variables, bleeding risk, dynamic reassessment, and post-discharge follow-up, aiming to provide guidance for standardized clinical prevention and treatment.

图1 胃肠外科围手术期VTE动态评估与防治流程图 注:VTE为静脉血栓栓塞症;MDT为多学科协作;ICU为重症监护病房
[1]
全国肺栓塞和深静脉血栓形成防治能力建设项目专家委员会《医院内静脉血栓栓塞症防治质量评价与管理指南(2022版)》编写专家组. 医院内静脉血栓栓塞症防治质量评价与管理指南(2022版)[J].中华医学杂志,2022,102(42): 3338-3348.
[2]
中国药师协会围手术期用药工作委员会,葛卫红. 围手术期静脉血栓栓塞症防治策略与药学监护专家共识[J]. 医药导报,2025,44(11): 1717-1735.
[3]
Lyman GH,Carrier M,Ay C,et al. American Society of Hematology 2021 Guidelines for Management of Venous Thromboembolism: Prevention and Treatment in Patients with Cancer[J].Blood Adv,2021,5(4): 927-974.
[4]
Key NS,Khorana AA,Kuderer NM,et al. Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer: ASCO Guideline Update[J].J Clin Oncol,2023,41(16): 3063-3071.
[5]
Farge D,Frere C,Connors JM,et al. 2022 International Clinical Practice Guidelines for the Treatment and Prophylaxis of Venous Thromboembolism in Patients with Cancer,Including Patients with COVID-19[J]. Lancet Oncol,2022,23(7): e334-e347.
[6]
Patel SV,Liberman SA,Burgess PL,et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Reduction of Venous Thromboembolic Disease in Colorectal Surgery[J]. Dis Colon Rectum,2023,66(9): 1162-1173.
[7]
Khorana AA,Mackman N,Falanga A,et al. Cancer-associated Venous Thromboembolism[J]. Nat Rev Dis Primers,2022,8(1): 11.
[8]
Hisada Y,Mackman N. Mechanisms of Cancer-associated Thrombosis[J]. Res Pract Thromb Haemost,2023,7: 100123.
[9]
Koizume S,Miyagi Y. Tissue Factor in Cancer-associated Thromboembolism: Possible Mechanisms and Clinical Applications[J]. Br J Cancer,2022,127(12): 2099-2107.
[10]
Rosell A,Martinod K,Mackman N,et al. Neutrophil Extracellular Traps and Cancer-associated Thrombosis[J]. Thromb Res,2022,213 Suppl 1.
[11]
Li JC,Zou XM,Yang SF,et al. Neutrophil Extracellular Traps Participate in the Development of Cancer-associated Thrombosis in Patients with Gastric Cancer[J]. World J Gastroenterol,2022,28(26): 3132-3149.
[12]
张再博,王冰雨,焦志凯,等. 胃癌术后下肢深静脉血栓危险因素的Meta分析[J/OL].中华普通外科学文献(电子版),2023,17(6): 475-480.
[13]
韩金昕,刘阳,熊振,等. 营养状态对腹腔镜胃癌围手术期静脉血栓栓塞症的影响[J/OL].中华腔镜外科杂志(电子版),2025,18(1): 19-24.
[14]
龙凯军,陈旺文,罗之谦. 胃癌病人术后发生静脉血栓栓塞症危险因素分析以及预测模型的建立[J]. 临床外科杂志,2024,32(1): 84-88.
[15]
吉林霞,范小春,梁琴. 胃癌常见术后并发症类型及危险因素研究进展[J/OL].中华普外科手术学杂志(电子版),2025,19(2): 220-223.
[16]
Wei Q,Wei ZQ,Jing CQ,et al. Incidence,Prevention,Risk Factors,and Prediction of Venous Thromboembolism in Chinese Patients after Colorectal Cancer Surgery: A Prospective,Multicenter Cohort Study[J]. Int J Surg,2023,109(10): 3003-3012.
[17]
张鹏,熊斌,童仕伦,等. 湖北省胃肠道肿瘤病人围手术期静脉血栓栓塞症多中心调查及分析[J]. 中国实用外科杂志,2021,41(7): 774-777,785.
[18]
刘倩,刘奎杰,王振奋,等. 胃肠外科手术患者术后下肢深静脉血栓形成危险因素分析[J/OL]. 中国医学前沿杂志(电子版),2021,13(2): 57-60.
[19]
Yao J,Lang Y,Su H,et al. Construction of Risk Assessment Model for Venous Thromboembolism after Colorectal Cancer Surgery: A Chinese Single-center Study[J]. Clin Appl Thromb Hemost,2022,28: 10760296211073748.
[20]
Lu X,Zeng W,Zhu L,et al. Application of the Caprini Risk Assessment Model for Deep Vein Thrombosis among Patients Undergoing Laparoscopic Surgery for Colorectal Cancer[J]. Medicine(Baltimore),2021,100(4): e24479.
[21]
Zhang W,Sun R,Hu X,et al. Caprini Risk Assessment Model Combined with D-dimer to Predict the Occurrence of Deep Vein Thrombosis and Guide Intervention after Laparoscopic Radical Resection of Colorectal Cancer[J]. World J Surg Oncol,2023,21(1): 299.
[22]
刘贤,兰春斌,胥彬,等. 肝切除术围手术期症状性静脉血栓栓塞症风险评估模型的建立及验证[J/OL]. 中华普外科手术学杂志(电子版),2022,16(3): 319-322.
[23]
Qin L,Liang Z,Xie J,et al. Development and Validation of Machine Learning Models for Postoperative Venous Thromboembolism Prediction in Colorectal Cancer Inpatients: A Retrospective Study[J]. J Gastrointest Oncol,2023,14(1): 220-232.
[24]
Wu D,Gu H,Tang Y,et al. Predictive Factors on Postoperative Venous Thromboembolism after Minimally Invasive Colorectal Cancer Surgery: A Retrospective Observational Study[J]. BMC Surg,2023,23(1): 85.
[25]
Zhang Y,Zhao Y,Cai J,et al. External Validation of Four Venous Thromboembolism Risk Assessment Models after Colorectal Cancer Surgery: A Retrospective Study[J]. Thromb J,2025,23(1): 92.
[26]
Irani JL,Hedrick TL,Miller TE,et al. Clinical Practice Guidelines for Enhanced Recovery after Colon and Rectal Surgery from the American Society of Colon and Rectal Surgeons and Society of American Gastrointestinal and Endoscopic Surgeons[J]. Dis Colon Rectum,2023,66(1): 15-40.
[27]
Kakkos SK,Gohel M,Baekgaard N,et al. European Society for Vascular Surgery Clinical Practice Guidelines on the Management of Venous Thrombosis[J]. Eur J Vasc Endovasc Surg,2021,61(1): 9-82.
[28]
Mazzolai L,Ageno W,Alatri A,et al. Second Consensus Document on Diagnosis and Management of Acute Deep Vein Thrombosis[J]. Eur J Prev Cardiol,2022,29(8): 1248-1263.
[29]
Stevens SM,Woller SC,Kreuziger LB,et al. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report[J]. Chest,2021,160(6): e545-e608.
[30]
Horlocker TT,Vandermeulen E,Kopp SL,et al. Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-based Guidelines: Fourth Edition[J]. Reg Anesth Pain Med,2018,43(3): 263-309.
[31]
Kopp SL,Vandermeulen E,McBane RD,et al. Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-based Guidelines: Fifth Edition[J/OL]. Reg Anesth Pain Med,2025.
[32]
Becattini C,Pace U,Pirozzi F,et al. Rivaroxaban vs Placebo for Extended Antithrombotic Prophylaxis after Laparoscopic Surgery for Colorectal Cancer[J]. Blood,2022,140(8): 900-908.
[33]
Choi JDW,Huynh N,Shepherd T,et al. The Efficacy and Safety of Extended Thromboprophylaxis after Colorectal Surgery: A Systematic Review and Meta-analysis[J]. Int J Colorectal Dis,2025,40(1): 211.
[34]
Zhou H,Chen TT,Ye LL,et al. Efficacy and Safety of Direct Oral Anticoagulants versus Low-molecular-weight Heparin for Thromboprophylaxis after Cancer Surgery: A Systematic Review and Meta-analysis[J]. World J Surg Oncol,2024,22(1): 69.
[35]
Guntupalli SR,Brennecke A,Behbakht K,et al. Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm: A Randomized Clinical Trial[J]. JAMA Netw Open,2020,3(6): e2010483.
[36]
Kaufman JA,Barnes GD,Chaer RA,et al. Society of Interventional Radiology Clinical Practice Guideline for Inferior Vena Cava Filters in the Treatment of Patients with Venous Thromboembolic Disease[J]. J Vasc Interv Radiol,2020,31(10): 1529-1544.
[37]
Borab ZM,Lanni MA,Tecce MG,et al. Use of Computerized Clinical Decision Support Systems to Prevent Venous Thromboembolism in Surgical Patients: A Systematic Review and Meta-analysis[J]. JAMA Surg,2017,152(7): 638-645.
[38]
Rastogi R,Lattimore CM,Mehaffey JH,et al. Electronic Health Record Risk-stratification Tool Reduces Venous Thromboembolism Events in Surgical Patients[J]. Surg Open Sci,2022,9: 34-40.
[39]
Zha H,Liu K,Tang T,et al. Acceptance of Clinical Decision Support System to Prevent Venous Thromboembolism among Nurses: An Extension of the UTAUT Model[J]. BMC Med Inform Decis Mak,2022,22(1): 221.
[40]
Tsaftaridis N,Goldin M,Spyropoulos AC. System-wide Thromboprophylaxis Interventions for Hospitalized Patients at Risk of Venous Thromboembolism: Focus on Cross-platform Clinical Decision Support[J]. J Clin Med,2024,13(7): 2133.
[41]
Loh S,Wijaya K,Rogers M,et al. A Clinical Decision Support Tool for Improving Venous Thromboembolism Risk Assessment and Thromboprophylaxis Prescribing Compliance within an Electronic Medication Management System: A Retrospective Observational Study[J]. Int J Clin Pharm,2025,47(3): 699-707.
[1] 吴姗姗, 潘裕民, 刘晋, 张劲松, 乔莉. 睡眠呼吸暂停综合征患者静脉血栓栓塞症发生率的Meta分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 312-317.
[2] 刘颂, 李秀, 陈莉, 宋鹏, 陆晓峰, 王萌, 管文贤. 基于示踪成像的真实情景教学在胃肠外科规范化培训中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(05): 506-508.
[3] 陈伟峰, 谢振华, 陈亮亮, 张曙伟, 唐莉. 肾移植术后移植肾静脉血栓形成七例临床诊治分析[J/OL]. 中华移植杂志(电子版), 2026, 20(03): 189-192.
[4] 关雪, 于颖, 李京, 刘莹, 崔亚娟, 刘名鹤. 肝移植受者术后下肢深静脉血栓形成风险预测模型的建立[J/OL]. 中华移植杂志(电子版), 2025, 19(03): 138-144.
[5] 陈令秋, 袁龙平, 王鹏, 王守磊, 张士豪. 直出式绿激光治疗围术期维持口服抗凝药的高龄高危前列腺增生患者的临床观察[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(05): 556-560.
[6] 丁镇涛, 邢博涵, 曲洋, 王泊江, 张培训. 老年肱骨近端骨折的围手术期治疗策略[J/OL]. 中华肩肘外科电子杂志, 2024, 12(04): 292-294.
[7] 周涛, 程梓荷, 郑宏芳, 刘佳奇, 许雪琴, 王胜昱. 脓毒症合并新发心房颤动抗凝治疗策略的研究进展[J/OL]. 中华重症医学电子杂志, 2025, 11(04): 402-406.
[8] 张丽娜, 谌楚宇, 杨新宇, 邱海波, 吕奔. 脓毒症凝血功能障碍:2024 年度进展与展望[J/OL]. 中华重症医学电子杂志, 2025, 11(02): 105-111.
[9] 于洁, 金小红, 顾艳楣, 王慧, 葛杨杨, 李燕. 癌症相关静脉血栓栓塞症患者疾病体验与需求的质性研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 739-744.
[10] 齐文翔, 黄昊, 顾建平, 周阳逸, 陆照璇, 苏浩波. AcoStream联合置管溶栓对于急/亚急性下肢深静脉血栓疗效对比[J/OL]. 中华介入放射学电子杂志, 2025, 13(04): 296-302.
[11] 植艳茹, 李海燕, 张晶晶, 钟亚宁. 基于课题研究型品管圈构建静脉血栓栓塞症防治护理“3E”教学模式[J/OL]. 中华介入放射学电子杂志, 2025, 13(02): 179-183.
[12] 李兰, 莫伟, 王庆, 胡琴, 李琴, 吴雅琴, 罗成林. 医院-社区-家庭一体化管理模式在社区老年人VTE 预防中的应用[J/OL]. 中华介入放射学电子杂志, 2025, 13(01): 88-92.
[13] 彭小蓉, 莫伟, 李琴, 吴雅琴, 李兰. 妊娠期妇女静脉血栓栓塞症预防的知信行现状及其影响因素分析[J/OL]. 中华介入放射学电子杂志, 2024, 12(03): 274-280.
[14] 肖瑶, 白玉瀛, 陶文丹, 吴波. 心房颤动治疗对认知功能影响的系统评价再评价[J/OL]. 中华脑血管病杂志(电子版), 2025, 19(03): 234-243.
[15] 周雅萍, 洪月慧, 苏宁, 刘暴, 朱铁楠, 倪俊. 脑淀粉样血管病合并易栓状态的临床治疗决策[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 338-344.
阅读次数
全文


摘要


AI
小
编
AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?